Article Synopsis
- Colorado legalized recreational marijuana in November 2012, with sales starting on January 1, 2014, becoming the first state to do so for adults over 21.
- In the years following legalization, Colorado has monitored the health impacts associated with this change in law.
- The paper discusses lessons learned regarding health behaviors, outcomes, and policy issues, aiming to inform other states considering similar legalization.
Video Abstracts
Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
In November 2012 Colorado voters approved legalized recreational marijuana. On January 1, 2014 Colorado became the first state to allow legal sales of non-medical marijuana for adults over the age of 21. Since that time, the state has been monitoring potential impacts on population health. In this paper we present lessons learned in the first three years following legal sales of recreational marijuana. These lessons pertain to health behaviors and health outcomes, as well as to health policy issues. Our intent is to share these lessons with other states as they face the prospect of recreational marijuana legalization.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ypmed.2017.02.021 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Developing a Mock Retail Cannabis Shop for Research: A Description of The CANNEX.
Cannabis
July 2025
Institute for Addiction Science, University of Southern California.
Objective: Cannabis retail dispensaries have proliferated in the United States in recent years, making it an important time for conducting research. Research is needed to learn more about consumer purchasing behaviors, including the impact of product marketing both inside and outside of retail spaces, and studies are needed to explore how both consumers and retail staff interpret the health benefits and potential risks associated with cannabis products within these environments. Current research on cannabis dispensaries often involves surveys or interviews with customers and dispensary staff outside of dispensary environments, but much can be learned through observational and experimental methods within dispensaries themselves.
View Article and Find Full Text PDFBudtender Perceptions and Knowledge of Cannabis and Mental Health: A Preliminary Study.
Cannabis
July 2025
Institute for Mental Health Policy and Research (IMHPR), Centre for Addiction and Mental Health (CAMH).
Objective: Legal cannabis dispensary employees ("Budtenders") are a significant resource for cannabis users. Current research indicates that cannabis use may adversely impact mental health. Public perception, however, is often inconsistent with this evidence, leading to increased use and disproportionate harm towards individuals with mental health disorders.
View Article and Find Full Text PDFMarketing Management and Policymaking for Medical Cannabis: Overcoming Barriers and Shaping Strategies.
Cannabis
July 2025
Department of Communication and Marketing, Faculty of Communication and Media Studies, Cyprus University of Technology.
Objective: Medical cannabis has emerged as a promising therapeutic option, but its market acceptance faces significant regulatory, societal, and scientific challenges. This study explores pharmaceutical business managers' perspectives on marketing strategies, brand architecture, and the value proposition of medical cannabis, aiming to identify approaches to overcome these barriers and guide policymaking.
Method: Semi-structured interviews were conducted with 12 pharmaceutical managers to explore key challenges and strategies.
Cannabis product exposures reported to Ramathibodi Poison Center, Thailand, during 2018-2022.
Clin Toxicol (Phila)
September 2025
Ramathibodi Poison Center, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Introduction: Cannabis was a category 5 narcotic in Thailand before legalization for medical use in February 2019. In June 2022, it was removed from the narcotics list.
Objectives: To characterize cannabis cases reported to a poison center in Thailand and to analyze the impact of medical and recreational legalization.
U.S. State Marijuana and Delta-8-Tetrahydrocannabinol Laws and Delta-8-Tetrahydrocannabinol Use.
Am J Prev Med
August 2025
The Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California; Qualcomm Institute, University of California San Diego, La Jolla, California. Electronic address:
Introduction: Delta-8-tetrahydrocannabinol has gained popularity since the passage of the 2018 U.S. Farm Bill.
View Article and Find Full Text PDF